Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

TIVDAK

TISOTUMAB VEDOTIN-TFTV

Standard Dose
40MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TIVDAK is listed in Drugs@FDA under application 761208 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TISOTUMAB VEDOTIN-TFTV Form and strength INJECTABLE;INJECTION - 40MG Sponsor SEAGEN Submission history Latest submission status date: 2025-11-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview TIVDAK is listed in Drugs@FDA under application 761208 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TISOTUMAB VEDOTIN-TFTV Form and strength INJECTABLE;INJECTION - 40MG Sponsor SEAGEN Submission history Latest submission status date: 2025-11-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.